AAA October 2017

BioGeneration Ventures seals third fund

Netherlands-based venture capital firm BioGeneration Ventures (BGV) closed its third fund at €82m ($95.5m) today, having secured capital from limited partners including pharmaceutical firms Bristol-Myers Squibb and Johnson & Johnson (J&J). The fund’s LPs also include European Investment Fund (EIF), private equity firm Schroder Adveq, and Man Pension Trust, which manages the pension funds of… Continue reading BioGeneration Ventures seals third fund